Robert L. Nussbaum - 03 Apr 2023 Form 4 Insider Report for Invitae Corp

Role
Chief Medical Officer
Signature
/s/ Thomas R. Brida, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
03 Apr 2023
Net transactions value
$0
Form type
4
Filing time
05 Apr 2023, 20:29:21 UTC
Previous filing
15 Mar 2023
Next filing
18 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVTA Common Stock Award $0 +155,000 +35% $0.000000 602,907 03 Apr 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares issuable upon settlement of a restricted stock unit award that vests in three equal installments, with 1/3 of the total award vesting on each of May 15, 2024, 2025 and 2026, subject to continued service with the issuer through the applicable vesting dates.
F2 Includes an aggregate of 427,028 shares of common stock issuable pursuant to restricted stock units that have not vested.